New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

BUFFALO, N.Y. — It is Alzheimer's Awareness Month, and it's a diseasearound one in nine people 65 and older in the United ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

Alzheimer's disease affects about 250,000 older adults in Illinois. Experts and those who have had to take care of loved ones ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

But perhaps the larger story associated with the unsurprising result is the market reaction, as Novo's shares fell by nearly 9% at the U.S. market open Monday.

Getting treatment within one week of a serious head injury can reduce the risk of developing Alzheimer's disease by up to 41% ...

A team of researchers at the Federal University of ABC (UFABC) in Brazil has developed a new chemical compound with the ...

Novo Nordisk announced Monday that in two closely watched studies, an oral version of semaglutide — the active ingredient in weight loss drugs — failed to help slow the progression of Alzheimer’s.

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...